Y Intercept (Hong Kong) LTD Adaptive Biotechnologies Corp Transaction History

Y Intercept (Hong Kong) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $157,369 - $266,317	67,252 New	67,252 $243,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $54,571 - $77,404	-8,816 Reduced 32.5%	18,310 $122,000
Q1 2023 May 09, 2023	BUY	$7.8 - $10.11 $211,582 - $274,243	27,126 New	27,126 $239,000
Q2 2022 Aug 08, 2022	SELL	$6.4 - $14.73 $95,206 - $219,123	-14,876 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $150,545 - $429,916	14,876 New	14,876 $206,000
Q2 2021 Aug 12, 2021	SELL	$32.22 - $44.59 $259,048 - $358,503	-8,040 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $135,887 - $247,047	3,647 Added 83.02%	8,040 $302,000
Q4 2020 Feb 05, 2021	BUY	$45.01 - $65.47 $197,728 - $287,609	4,393 New	4,393 $261,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.